RxDoctor Payments DataLook up a doctor →

Phillip Cox, DO

Critical Care Medicine · South Charleston, WVNPI 1629262944

Payments from drug & device makers

$20,226in general payments, 2019–2025

Across 577 payments — averaging $35.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Pulmonx Corporation$3K
  • AstraZeneca$2K
  • Johnson & Johnson$2K
  • GSK$1K
  • Regeneron Healthcare Solutions, Inc.$991
  • plus $6K from 34 others

What the payments were for

  • Travel & lodging$4,72323%
  • Food & beverage$12,37261%
  • Education$3,13015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,226 in reported general payments places this provider in the 95th percentile of 29 critical care medicine providers in West Virginia.

See all critical care medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$237,961
Medicare patients
1,087
Services billed
2,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter348$346,687
OfevNintedanib Esylate22$285,969
Aralast NpAlpha-1-Proteinase Inhibitor12$194,341
Breztri AerosphereBudesonide/Glycopyr/Formoterol216$162,185
Dupixent PenDupilumab26$101,622
Spiriva RespimatTiotropium Bromide128$98,833
Fasenra PenBenralizumab12$67,187
Breo ElliptaFluticasone/Vilanterol113$59,202
SymbicortBudesonide/Formoterol Fumarate169$56,006
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr79$40,051
Spiriva HandihalerTiotropium Bromide63$39,135
Stiolto RespimatTiotropium Br/Olodaterol Hcl42$28,567
EliquisApixaban25$25,907
Pirfenidone26$19,646
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate69$18,217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$1,487$459,657570 claims
Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat$920$422,744208 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,219$218,191385 claims
PfizerEliquis$120$25,90725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 29 critical care medicine providers in West Virginia.

Other critical care medicine in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →